Journal article
Gadolinium-Based Contrast Agents in Kidney Disease: Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists
Abstract
Use of gadolinium-based contrast agents (GBCAs) in renal impairment is controversial, with physician and patient apprehension in acute kidney injury (AKI), chronic kidney disease (CKD), and dialysis because of concerns regarding nephrogenic systemic fibrosis (NSF). The position that GBCAs are absolutely contraindicated in AKI, CKD stage 4 or 5 (estimated glomerular filtration rate [eGFR] <30 mL/min/1.73 m2) and dialysis-dependent patients is …
Authors
Schieda N; Blaichman JI; Costa AF; Glikstein R; Hurrell C; James M; Maralani PJ; Shabana W; Tang A; Tsampalieros A
Journal
Canadian Association of Radiologists Journal, Vol. 69, No. 2, pp. 136–150
Publisher
SAGE Publications
Publication Date
May 2018
DOI
10.1016/j.carj.2017.11.002
ISSN
0846-5371